Back when Indian IT companies were the rage, Rakesh Jhunjhunwala was gaining fame for his investments in ‘old economy’ businesses. One of them was his bet on pharma major Lupin, in which he had picked up 1% stake (500,000 shares) in December 2002. That he was enamoured by the Mumbai-based company was evident in the way he ramped up his holding in the subsequent four quarters to 4.25%, by December 2003. His second big pharma bet was in 2013 when he entered Aurobindo Pharma, which was trading at an average price of Rs.150 in the December quarter.
What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet